9/25/2007

Encysive Pharmaceuticals said it will conduct another Phase III clinical trial for its experimental hypertension drug Thelin, which has been denied FDA approval several times. The company said it will collaborate with the agency to finish a protocol for the late-stage study of the drug candidate.

Related Summaries